Nephrology Forum

Kidney International (1980) 17, 118–134; doi:10.1038/ki.1980.14

Hyperkalemia and hyporeninemic hypoaldosteronism

Presentation of the Forum is made possible by grants from Hoechst-Roussel Pharmaceuticals Inc., Smith Kline & French Laboratories, G.D. Searle & Co., Warner-Lambert Pharmaceutical Division, Burroughs Wellcome Company, Geigy Pharmaceuticals Inc., Ciba Pharmaceuticals Inc., and Boehringer Ingel-heim Ltd.

Principal Discussant: Ralph A DeFronzo1

1Department of Medicine, Yale University School of Medicine, New Haven, Connecticut

Correspondence: Dr Ralph DeFronzo, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06510, USA

Top

References

  1. Malnic G, Klose RM, Giebisch G: Micropuncture study of renal potassium excretion in the rat. Am J Physiol 206:674–686, 1974
  2. Malnic G, Klose RM, Giebisch G: Micropuncture study of distal tubular potassium and sodium transport in rat nephron. Am J Physiol 211:529–547, 1966 | PubMed | ISI | ChemPort |
  3. Wright FS, Giebisch G: Renal potassium transport: contributions of individual nephron segments and populations. Am J Physiol 235:F515–F527, 1978
  4. Reineck HJ, Osgood RW, Stein JH: Net potassium addition beyond the superficial distal tubule of the rat. Am J Physiol 235:F104–F110, 1978
  5. Hierholzer K: Secretion of potassium and acidification in collecting ducts of mammalian kidney. Am J Physiol 201:318–324, 1961
  6. Finkelstein FO, Hayslett JP: Role of medullary structures in the functional adaptation of renal insufficiency. Kidney Int 6:419–425, 1974
  7. Silva P, Ross BD, Charney AN, Besarab A, Epstein FH: Potassium transport by the isolated perfused kidney. J Clin Invest 56:862–869, 1975
  8. Giebisch G: The distal tubular potassium transport system, in New Aspects of Renal Function, edited by Vogel HG, Ullrich KH, Amsterdam, Excerpta Medica, 1978, vol. 6, pp. 137–146
  9. Good DW, Wright FS: Effects of sodium reabsorption, transepithelial voltage and flow rate on potassium secretion in renal distal tubule. Kidney Int 12:558, 1977 (abst)
  10. Irvine ROH, Dow J: Muscle cell pH and potassium movement in metabolic acidosis. Metabolism 17:563–570, 1968
  11. McCaa RE, McCaa CS, Guyton AC: Role of angiotensin II and potassium in the long term regulation of aldosterone secretion in intact conscious dogs. Circ Res: Suppl. 1 to volumes 36 and 37:157–167, 1975
  12. DeFronzo RA, Sherwin RS, Dillingham M, Hendler R, Tamborlane WV, Felig P: Influence of basal insulin and glucagon secretion on potassium and sodium metabolism. J Clin Invest 61:472–479, 1978
  13. Kunau RT, Whinnery MA: Potassium transfer in distal tubule of normal and remnant kidneys. Am J Physiol 235:F186–F191, 1978
  14. Schultze RG, Taggart DD, Shapiro H, Pennell JP, Caglar S, Bricker NS: On the adaptation in potassium excretion associated with nephron reduction in the dog. J Clin Invest 50:1061–1068, 1971
  15. Hayslett J: Functional adaptation to reduction in renal mass. Physiol Rev 59:137–164, 1979 | PubMed | ISI | ChemPort |
  16. Hayes CP, McLeod ME, Robinson RR: An extrarenal mechanism for the maintenance of potassium balance in severe chronic renal failure. Trans Assoc Am Physicians 80:207–216, 1967 | PubMed |
  17. Alexander EA, Levinsky NG: An extrarenal mechanism of potassium adaptation. J Clin Invest 47:740–748, 1968 | PubMed | ISI | ChemPort |
  18. Gonick HC, Kleeman CR, Rubini ME, Maxwell MH: Functional impairment in chronic renal disease. III. Studies of potassium excretion. Am J Med Sci 261:281–290, 1971 | ISI | ChemPort |
  19. DeFronzo RA, Taufield PA, Black H, McPhedran P, Cooke CR: Impaired renal tubular potassium secretion in sickle cell disease. Ann Intern Med 90:310–316, 1979 | PubMed | ChemPort |
  20. Clapp JR, Rector FC, Seldin DW: Effect of unreabsorbed anions on proximal and distal transtubular potentials in the rat. Am J Physiol 202:781–786, 1962
  21. Cade R, Shalhoub R: The effect of mineralocorticoids on renal handling of potassium. J Clin Invest 40:1028, 1961
  22. Roseman MK, Sehy JT, Arruda JAL, Kurtzman NA: Studies on the mechanism of hyperkalemic distal renal tubular acidosis (dRTA): gradient type RTA in SC hemoglobinopathy. Kidney Int 12:473, 1977
  23. Michelis MF, Murdaugh HV: Selective hypoaldosteronism. Am J Med 59:1–5, 1975
  24. Fredlund P, Saltman S, Dando J, Douglas J, Catt KJ: Aldosterone production by isolated glomerulosa cells: modulation of sensitivity to angiotensin II and ACTH by extracellular potassium concentration. Endocrinology 100:481–486, 1977
  25. Haning R, Tait SAS, Tait JF: In vitro effects of ACTH, angiotensin, serotonin and potassium on steroid output and conversion of corticosterone to aldosterone by isolated adrenal cells. Endocrinology 87:1147–1167, 1975
  26. Hudson J, Chobanian A, Relman A: Hypoaldosteronism. A clinical study of a patient with an isolated adrenal mineralocorticoid deficiency, resulting in hyperkalemia and Stokes-Adams attacks. N Engl J Med 257:529–536, 1957
  27. Skanse B, Hokfelt B: Hypoaldosteronism with otherwise intact adrenocortical function, resulting in a characteristic clinical entity. Acta Endocrinol 28:29–36, 1958
  28. Hill S, Nickerson J, Chenault S, McNeil J, Starnes W, Gautney M: Studies in man on hyper- and hypoaldosteronism. Arch Intern Med 104:982–994, 1959
  29. Lambrew C, Carver S, Peterson R, Horwith M: Hypoaldosteronism as a cause of hyperkalemia and syncopal attacks in a patient with complete heart block. Am J Med 31:81–85, 1961
  30. Ulick S, Gautier E, Vetter K, Markello J, Yaffe S, Lowe C: An aldosterone biosynthetic defect in a salt-losing disorder. J Clin Endocrinol Metab 24:669–672, 1964
  31. Wilson I, Goetz F: Selective hypoaldosteronism after prolonged heparin administration. Am J Med 36:635–640, 1964
  32. Posner J, Jacobs D: Isolated analdosteronism. I. Clinical entity, with manifestations of persistent hyperkalemia, periodic paralysis, salt-losing tendency, and acidosis. Metabolism 13:513–521, 1964
  33. Gerstein A, Kleeman C, Gold E, Franklin S, Maxwell M, Gonick H, Feffer M, Steinman T: Aldosterone deficiency in chronic renal failure. Nephron 5:90–105, 1968
  34. Christlieb A, Hickler R, Lauler D, Williams G: Hypertension with inappropriate aldosterone stimulation. A syndrome. N Engl J Med 281:128–131, 1969
  35. Vagnucci A: Selective aldosterone deficiency. J Clin Endocrinol Metab 29:279–289, 1969
  36. Vagnucci A: Selective aldosterone deficiency in chronic pyelonephritis. Nephron 7:524–537, 1970
  37. Ferrara E, Werk E, Hanenson I, Privitera P, Kenyon C: Selective hypoaldosteronism with blunted renin-activity responsiveness. Clin Res 18:602, 1970
  38. McGiff J, Muzzarelli R, Duffy P, Gonzalez Y, Pierce C, Frawley T: Interrelationships of renin and aldosterone in a patient with hypoaldosteronism. Am J Med 48:247–252, 1970
  39. Stockigt J, Collins R, Schambelan M, Brust N, Biglieri E: Subordinate hypoaldosteronism. Clin Res 19:174, 1971
  40. Perez G, Siegel L, Schreiner G: Selective hypoaldosteronism with hyperkalemia. Ann Intern Med 76:757–763, 1972
  41. Mellinger R, Petermann F, Jurgenson J: Hyponatremia with low urinary aldosterone occurring in an old woman. J Clin Endocrinol Metab 34:85–91, 1972
  42. Schambelan M, Stockigt J, Biglieri E: Isolated hypoaldosteronism in adults. A renin-deficiency syndrome. N Engl J Med 287:573–578, 1972
  43. Brown J, Chinn R, Fraser R, Lever A, Morton J, Robertson J, Tree M, Waite M: Recurrent hyperkalemia due to selective aldosterone deficiency: Correction by angiotensin infusion. Br Med J 1:650–654, 1973
  44. Gossain V, Ferrara E, Werk E, Srivastava L, Privitera P, Hanenson I: Impaired renin responsiveness with secondary hypoaldosteronism. Arch Intern Med 132:885–890, 1973
  45. Weidmann P, Reinhart R, Maxwell M, Rowe P, Coburn J, Massry S: Syndrome of hyporeninemic hypoaldosteronism and hyperkalemia in renal disease. J Clin Endocrinol Metab 36:965–977, 1973
  46. Oh M, Carroll H, Clemmons J, Vagnucci A, Levinson S, Whang E: A mechanism for hyporeninemic hypoaldosteronism in chronic renal disease. Metabolism 23:1157–1166, 1974
  47. Weidmann P, Maxwell M, Rowe P, Winer R, Massry S: Role of the renin-angiotensin-aldosterone system in the regulation of plasma potassium in chronic renal disease. Nephron 15:35–49, 1975 | ISI | ChemPort |
  48. Goldfarb S, Cox M, Singer I, Goldberg M: Acute hyperkalemia induced by hyperglycemia: hormonal mechanisms. Ann Intern Med 84:426–432, 1976
  49. Goldfarb S, Strunk B, Singer I, Goldberg M: Paradoxical glucose-induced hyperkalemia. Am J Med 59:744–750, 1975
  50. Syzlman P, Better O, Chaimowit C, Rosler A: Role of hyperkalemia in the metabolic acidosis of isolated hypoaldosteronism. N Engl J Med 294:361–365, 1976
  51. DeLeiva A, Christlieb R, Melby J, Graham C, Day R, Luetscher J, Zager P: Big renin and biosynthetic defect of aldosterone in diabetes mellitus. N Engl J Med 295:639–643, 1976
  52. Perez G, Lespier L, Knowles R, Oster J, Vaamonde C: Hyporeninemia and hypoaldosteronism in diabetes mellitus. Arch Intern Med 137:852–855, 1977 | PubMed |
  53. Arora KK, Pfeifer MA, Wolter C, Melo J, Samols E: Hyperkalemia due to selective hypoaldosteronism. South Med J 70:634–636, 1977
  54. Barbour GL, Keller AW: Distal renal tubular acidosis in selective hypoaldosteronism. South Med J 71:1397–1400, 1978
  55. Perez GO, Lespier L, Knowles R, Oster JR, Vaamonde CA: Potassium homeostasis in chronic diabetes mellitus. Arch Intern Med 137:1018–1022, 1977
  56. Brezis M, Litvin Y: Syndrome of hyporeninemic hypoaldosteronism. Israel J Med 13:1013–1021, 1977
  57. Sebastian A, Schambelan M, Lindenfield S, Morris C: Amelioration of metabolic acidosis with fludrocortisone therapy in hyporeninemic hypoaldosteronism. N Engl J Med 297:576–583, 1977
  58. Norby LH, Ramwell P, Weidig J, Slotkoff L, Flamenbaum W: Possible role for impaired renal prostaglandin production in pathogenesis of hyporeninaemic hypoaldosteronism. Lancet 2:1118–1122, 1978
  59. Perez GO, Lespier LE, Oster JR, Vaamonde CA: EflFect of alterations of sodium intake in patients with hyporeninemic hypoaldosteronism. Nephron 18:259–265, 1977
  60. Sparagana M: Hyporeninemic hypoaldosteronism with diabetic glomerulosclerosis. Biochemical Med 14:93–103, 1975
  61. Christlieb AR, Kaldany A, D'Elia JA, Williams GH: Aldosterone responsiveness in patients with diabetes mellitus. Diabetes 27:732–737, 1978
  62. Tait JF, Tait SAS: The effect of changes in potassium concentration on the maximal steroidogenic response of purified zona glomerulosa cells to angiotensin II. J Steroid Biochem 7:687–690, 1976
  63. Bayard F, Cooke CR, Tiller DJ, Beitins IS, Kowarski A, Walker GW, Migeon CJ: The regulation of aldosterone secretion in anephric man. J Clin Invest 50:1585–1595, 1970
  64. Mitra S, Genuth SM, Berman LB, Vertes V: Aldosterone secretion in anephric patients. N Engl J Med 286:61–64, 1972
  65. McCaa RE, McCaa CS, Read DG, Bower ID, Guyton AC: Increased plasma aldosterone concentration in response to hemodialysis in nephrectomized man. Circ Res 31:473–480, 1972
  66. Brunner HR, Baer L, Sealey JE, Ledingham JGG, Laragh JH: The influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects. J Clin Invest 49:2128–2138, 1970 | PubMed | ISI | ChemPort |
  67. Schneider EG, Lynch RE, Willis LR, Knox FG: The effect of potassium infusion on proximal sodium reabsorption and renin release in the dog. Kidney Int 2:197–202, 1972
  68. Sealey JE, Clark I, Bull MB, Laragh JH: Potassium balance and the control of renin secretion. J Clin Invest 49:2119–2127, 1970
  69. Andres RM, Baltzan MA, Cader G, Zierler KL: Effeet of insulin on carbohydrate metabolism and on potassium in the forearm of man. J Clin Invest 41:108–115, 1962 | PubMed | ISI | ChemPort |
  70. Zierler KL: Effect of insulin on potassium efflux from rat muscle in the presence and absence of glucose. Am J Physiol 198:1066–1070, 1960 | PubMed | ChemPort |
  71. DeFronzo RA, Felig P, Ferrannini E, Wahren J: Sites and mechanism of insulin mediated potassium metabolism in man. Clin Res 27:365A, 1979
  72. Mortimore GE: Effect of insulin on potassium transfer in isolated rat liver. Am J Physiol 200:1315–1319, 1961
  73. Kestens PJ, Haxhe JJ, Lambotte L, Lambotte C: The effect of insulin on the uptake of potassium and phosphate by the isolated perfused canine liver. Metabolism 12:941–950, 1963
  74. Brown RD, Strott CA, Liddle GW: Site of stimulation of aldosterone biosynthesis by angiotensin and potassium. J Clin Invest 51:1413–1418, 1972
  75. deChatel R, Weidmann P, Flammer J, Ziegler WH, Beretta-Piccoli C, Vetter W, Reubi FC: Sodium, renin, aldosterone, catecholamines, and blood pressure in diabetes mellitus. Kidney Int 12:412–421, 1977
  76. Thomsen AC: The significance of renal biopsy for the diagnosis of pyelonephritis in diabetic patients, in Ciba Foundation Symposium on Renal Biopsy, edited by Wolstenholme GEW, Cameron MP, Boston, Little, Brown & Co., 1961, p. 281
  77. Heptinstall RH: Pathology of the Kidney, Second edition. Boston, Little, Brown & Co., 1974, pp. 940–941
  78. Arieff AI: Kidney, water and electrolyte metabolism in diabetes mellitus, in The Kidney, edited by Brenner BM, Rector FC. Philadelphia, W. B. Saunders Co., 1976, pp. 1257–1296
  79. Schindler AM, Sommers SC: Diabetic sclerosis of the renal juxtaglomerular apparatus. Lab Invest 15:877–884, 1966
  80. Day RP, Leutscher JA, Gonzales CM: Occurrence of big renin in human plasma, amniotic fluid, and kidney extracts. J Clin Endocrinol Metab 40:1078–1084, 1975
  81. Wagermark J, Ungersted U, Ljungquist A: Sympathetic innervation of the juxtaglomerular cells of the kidney. Circ Res 22:149–153, 1968
  82. DeChamplain J, Genest J, Vegratt R: Factors controlling renin in man. Arch Intern Med 117:355–363, 1966
  83. Christensen NJ: Plasma catecholamines in long-term diabetes with and without neuropathy and in hypophysectomized subjects. J Clin Invest 51:779–787, 1972
  84. Tuck ML, Sambhi MP, Levin L: Hyporeninemic hypoaldosteronism in diabetes mellitus. Studies of the autonomic nervous system's control of renin release. Diabetes 28:237–241, 1978
  85. Yun J, Kelly G, Bartter FC, Smith H: Role of prostaglandins in the control of renin secretion in the dog. Circ Res 40:459–464, 1977 | PubMed | ChemPort |
  86. Romero JC, Dunlap CL, Strong CG: The effect of indomethacin and other anti-inflammatory drugs on the renin-angiotensin system in man. J Clin Invest 58:282–288, 1976
  87. Tan SY, Mulrow PJ: Inhibition of the renin-aldosterone response to furosemide by indomethacin. J Clin Endocrinol Metab 45:174–176, 1977
  88. Saruta T, Kaplan NM: Adrenocortical steroid genesis: the effects of prostaglandins. J Clin Invest 51:2246–2251, 1972
  89. Tan SY, Shapiro R, Franco R, Stockard H, Mulrow PJ: Indomethacin-induced prostaglandin inhibition with hyperkalemia. Ann Intern Med 90:783–785, 1979
  90. Tan SY, Antonipillai I, Mulrow PJ: Inactive renin and impaired prostaglandin production in hyporeninemic hypoaldosteronism. Clin Res 29:452A, 1979
  91. Hahn JA, Zipser RD, Zia PK, Horton R: Prostaglandins in hyporeninaemic hypoaldosteronism. Lancet 1:1379, 1978
  92. Hahn JA, Zipser RD, Stone RA, Zia PK, Horton R: Vasoactive systems in hyporeninaemic hypoaldosteronism: deficiency of kallikrein. Clin Res 27:313A, 1979
  93. Adler S: An extrarenal action of aldosterone on mammalian skeletal muscle. Am J Physiol 218:616–621, 1970
  94. Bia M, Lee R, Jones A, DeFronzo RA: Role of insulin and adrenal hormones in acute potassium homeostasis. Clin Res 27:409A, 1979
  95. DeFronzo RA, Goldberg M, Cooke CR, Barker C, Grossman RA, Agus ZS: Investigations into the mechanisms of hyperkalemia following renal transplantation. Kidney Int 11:357–365, 1977
  96. Pardo V, Strauss J, Kramer H, Ozawa T, McIntosh RM: Nephropathy associated with sickle cell anemia. An autologous immune complex nephritis. II. Clinicopathologic study of seven patients. Am J Med 59:650–659, 1975 | Article | PubMed | ISI | ChemPort |
  97. Brentjens JR, Sepulveda M, Balliah T, Bentzel C, Erlanger BF, Elwood CL, Montes M, Hsu KC, Andres GA: Interstitial immune complex nephritis in patients with systemic lupus erythematosus. Kidney Int 7:342–350, 1975
  98. DeFronzo RA, Cooke CR, Goldberg M, Cow M, Myers AR, Agus ZS: Impaired renal tubular potassium secretion in systemic lupus erythematosus. Ann Intern Med 86:268–271, 1977
  99. Saruta T, Kaplan NM. Adrenocortical steroidogenesis: The effects of prostaglandin. J Clin Invest 51:2246–2251, 1972
  100. Tan SY, Mulrow PJ. Inhibition of the renin-aldosterone response to furosemide by indomethacin. J Clin Endocrinol Metab 45:174–176, 1977
  101. Veldhuis JD, Kulin HE, Santen RJ, Wilson TE, Melby JC. Inherited isolated deficiency of corticosterone methyloxidase Type II (CMO-II). Clin Res 1979 (in press)
  102. Rosler A, Rabinowitz O, Theodor R, Ramirez LC, Vlick S. The nature of the defect in a salt wasting disorder in Jews in Iran. J Clin Endocrinol Metab 44:279–291, 1977
  103. Cohen JJ, Hulter HN, Smithline NS, Melby JC, Schwartz WB: The critical role of the adrenal gland in the renal regulation of acid-base equilibrium during chronic hypotonic expansion: evidence that chronic hyponatremia is a potent stimulus to aldosterone secretion. J Clin Invest 58:1201–1208, 1976
  104. Walker WG, Cooke CR: Plasma aldosterone regulation in anephric man. Kidney Int 3:1–5, 1973
  105. Oh MS, Carroll HJ, Goldstein DA, Fein IA: Hyperchloremic acidosis during the recovery phase of diabetic ketoacidosis. Ann Intern Med 89:925–927, 1978
  106. Ostes JR, Perez GO, Rosen MS: Hyporeninemic hypoaldosteronism after chronic bicarbonate abuse. Arch Intern Med 136:1179–1181, 1976
  107. Perez GO, Ostes JR, Vaamonde CA: Renal acidification in patients with mineralocorticoid deficiency. Nephron 17:461–473, 1976
  108. Cohen JJ, Lyons H, Harrington JT, Schwartz WB: Total correction by DOCA of HCl-induced chronic metabolic acidosis. Clin Res 21:681, 1973
  109. Hulter HN, Ilnocki LP, Harlottle JA, Sebastian A: Impaired renal H+ secretion and NH3 production in mineralocorticoid-deficient glucocorticoid-replete dogs. Am J Physiol 232:F136–F146, 1977

Extra navigation

.
ADVERTISEMENT